Pulmonary Arterial Hypertension

The AJMC® Pulmonary Arterial Hypertension compendium is a comprehensive resource for clinical news and expert insights for the progressive disorder, which is characterized by high blood pressure in the arteries that go from the heart to the lungs.

Latest News

Melatonin | Image Credit: JEGAS RA-stock.adobe.com
Melatonin's Role in PAH Treatment Needs More Research

June 27th 2025

Previous knowledge on melatonin use for pulmonary arterial hypertension has primarily been gathered from animal studies, with oxidative stress implicated in the disease’s progression and severity.

Family discussion on PAH care | Image Credit: Maggie L. Shaw/sora.chatgpt.com
Family Key to PAH Care for Women, but Gaps Remain

June 18th 2025

Echocardiography | Image Credit: Tamer-stock.adobe.com
TPIP a Potential Game-Changer for Prostanoid Therapy in PAH

June 11th 2025

Anjali Vaidya, MD, FACC, FASE, FACP | Image Credit: Temple University Hospital
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide

June 4th 2025

PAH X-ray with pen | Image credit: Dzmitry – stock.adobe.com
Sotatercept for PAH Maintains Safety, Reduced Mortality in Long-Term Follow-Up

May 30th 2025

Transforming PAH Management Through Innovation and Strategic Care

Learn how novel therapies, early diagnosis, and personalized treatment approaches are advancing PAH care while addressing clinical needs, patient preferences, and economic impact.

AJMC Stakeholder Summit logo displayed on a light blue and white scientific background with hexagonal molecular graphics and connecting lines.

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo